🇺🇸 FDA
Patent

US 9850468

Infectious hepatitis E virus genotype 3 recombinants

granted A61KA61K39/00A61P

Quick answer

US patent 9850468 (Infectious hepatitis E virus genotype 3 recombinants) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Dec 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K39/00, A61P, A61P1/16, A61P31/14